Join
Live feed
·
INSIDERFilingvia Quantisnow
Candel Therapeutics Inc. logo

Amendment: Chief Technology Officer Tyagarajan Seshu exercised 20,000 shares at a strike of $1.29 and sold $275,947 worth of shares (31,278 units at $8.82), decreasing direct ownership by 12% to 85,512 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CADL (Candel Therapeutics Inc.) and more on Quantisnow.